Industry
Corvia Medical
Total Trials
8
Recruiting
1
Active
5
Completed
2
Success Rate
66.7%-20% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
Failure Rate
12.5%
1 terminated/withdrawn out of 8 trials
Success Rate
66.7%
-19.8% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
7(100.0%)
7Total
N/A(7)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (8)
Showing 8 of 8 trials
NCT05425459Not ApplicableActive Not Recruiting
RESPONDER-HF Trial
Role: lead
NCT03191656Recruiting
REDUCE LAP-HF III Corvia Protocol 1701
Role: lead
NCT03093961Not ApplicableActive Not Recruiting
REDUCE LAP-HFREF TRIAL
Role: lead
NCT02600234Not ApplicableActive Not Recruiting
REDUCE LAP-HF RANDOMIZED TRIAL I
Role: lead
NCT03088033Not ApplicableActive Not Recruiting
REDUCE LAP-HF TRIAL II
Role: lead
NCT04632160Not ApplicableWithdrawn
Extended IASD Investigation: REDUCE LAP-HF IV
Role: lead
NCT01570517Not ApplicableCompleted
Feasibility Trial of the DC Devices Interatrial Septal Device (IASD) System
Role: lead
NCT01913613Not ApplicableCompleted
REDUCE LAP-HF TRIAL
Role: lead
All 8 trials loaded